Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
diosmetine (1 trial)
Hesperedin (1 trial)
Venous Insufficiency (Phase 3)
Trials (1 total)
Trial APIs (2 total)